Zhang J, Xiong C, Wei X, Yang H, Zhao C
Methods Mol Biol. 2024; 2883:377-402.
PMID: 39702718
DOI: 10.1007/978-1-0716-4290-0_17.
Ferro E, Szischik C, Cunial M, Ventura A, De Martino A, Bosia C
Methods Mol Biol. 2024; 2883:167-193.
PMID: 39702709
DOI: 10.1007/978-1-0716-4290-0_8.
Pan C, Chen Y
BMC Bioinformatics. 2024; 25(1):382.
PMID: 39695935
PMC: 11658358.
DOI: 10.1186/s12859-024-05996-z.
To K, Zhang H, Cho W
Cancer Drug Resist. 2024; 7:37.
PMID: 39403602
PMC: 11472581.
DOI: 10.20517/cdr.2024.66.
Poliseno L, Lanza M, Pandolfi P
Cell Res. 2024; 34(9):609-629.
PMID: 39054345
PMC: 11369213.
DOI: 10.1038/s41422-024-00975-8.
Role of miRNAs in neurovascular injury and repair.
Sawant H, Sun B, Mcgrady E, Bihl J
J Cereb Blood Flow Metab. 2024; 44(10):1693-1708.
PMID: 38726895
PMC: 11494855.
DOI: 10.1177/0271678X241254772.
Potential Intersections between lncRNA, Vascular Cognitive Impairment, and Immunization Strategies: Insights and Future Directions.
Fan Y, Xiao B, Zhang M
Vaccines (Basel). 2024; 12(3).
PMID: 38543885
PMC: 10975926.
DOI: 10.3390/vaccines12030251.
RUNX1/NPM1/H3K4me3 complex contributes to extracellular matrix remodeling via enhancing FOSL2 transcriptional activation in glioblastoma.
Cui X, Huo D, Wang Q, Wang Y, Liu X, Zhao K
Cell Death Dis. 2024; 15(1):98.
PMID: 38286983
PMC: 10825180.
DOI: 10.1038/s41419-024-06481-4.
Vof16-miR-185-5p-GAP43 network improves the outcomes following spinal cord injury via enhancing self-repair and promoting axonal growth.
Hu Y, Sun Y, Yuan H, Liu J, Chen L, Liu D
CNS Neurosci Ther. 2024; 30(4):e14535.
PMID: 38168094
PMC: 11017428.
DOI: 10.1111/cns.14535.
Differentially expressed miRNAs associated with generalized aggressive periodontitis.
Guzeldemir-Akcakanat E, Sunnetci-Akkoyunlu D, Balta-Uysal V, Ozer T, Isik E, Cine N
Clin Oral Investig. 2023; 28(1):7.
PMID: 38123758
DOI: 10.1007/s00784-023-05404-5.
PanomiR: a systems biology framework for analysis of multi-pathway targeting by miRNAs.
Yeganeh P, Teo Y, Karagkouni D, Pita-Juarez Y, Morgan S, Slack F
Brief Bioinform. 2023; 24(6).
PMID: 37985452
PMC: 10661971.
DOI: 10.1093/bib/bbad418.
The network structure of hematopoietic cancers.
Nakamura-Garcia A, Espinal-Enriquez J
Sci Rep. 2023; 13(1):19837.
PMID: 37963971
PMC: 10645882.
DOI: 10.1038/s41598-023-46655-2.
, , microRNAs, and ceRNA Networks: Precision Targeting in Cancer Therapeutics.
Travis G, McGowan E, Simpson A, Marsh D, Nassif N
Cancers (Basel). 2023; 15(20).
PMID: 37894321
PMC: 10605164.
DOI: 10.3390/cancers15204954.
Tumor-specific polycistronic miRNA delivered by engineered exosomes for the treatment of glioblastoma.
McDonald M, Hossain A, Momin E, Hasan I, Singh S, Adachi S
Neuro Oncol. 2023; 26(2):236-250.
PMID: 37847405
PMC: 10836765.
DOI: 10.1093/neuonc/noad199.
Effects of microRNA-mediated negative feedback on gene expression noise.
Adhikary R, Roy A, Jolly M, Das D
Biophys J. 2023; 122(21):4220-4240.
PMID: 37803829
PMC: 10645566.
DOI: 10.1016/j.bpj.2023.09.019.
Long noncoding RNA HOTAIR promotes breast cancer development through the lncRNA HOTAIR/miR-1/GOLPH3 axis.
Zhao J, Zhang L, Zhao Y, Wu N, Zhang X, Guo R
Clin Transl Oncol. 2023; 25(12):3420-3430.
PMID: 37099061
DOI: 10.1007/s12094-023-03197-3.
spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape.
Boniolo F, Hoffmann M, Roggendorf N, Tercan B, Baumbach J, Castro M
Bioinformatics. 2023; 39(5).
PMID: 37084275
PMC: 10220456.
DOI: 10.1093/bioinformatics/btad276.
A cytosine-patch sequence motif identified in the conserved region of lincRNA-p21 interacts with the KH3 domain of hnRNPK.
Maulik A, Bandopadhyay D, Singh M
Curr Res Struct Biol. 2023; 5:100099.
PMID: 36941955
PMC: 10023864.
DOI: 10.1016/j.crstbi.2023.100099.
Exosomal microRNAs in cancer: Potential biomarkers and immunotherapeutic targets for immune checkpoint molecules.
Alotaibi F
Front Genet. 2023; 14:1052731.
PMID: 36873941
PMC: 9982116.
DOI: 10.3389/fgene.2023.1052731.
The role of miR-128 in cancer development, prevention, drug resistance, and immunotherapy.
Setia Budi H, Younus L, Hadi Lafta M, Parveen S, Mohammad H, Al-Qaim Z
Front Oncol. 2023; 12:1067974.
PMID: 36793341
PMC: 9923359.
DOI: 10.3389/fonc.2022.1067974.